<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="project_funders\PMC6695091\results\search\funders\results.xml">
  <result pre="Gynecology: Pregnancy : Medicine and Health Sciences : Pharmacology: Drug" exact="Research and Development" post=": People and Places : Population Groupings : Age"/>
  <result pre="D.2http://orcid.org/0000-0002-9280-1950Garcia-PratsAnthony J.3http://orcid.org/0000-0001-8884-3384McIntireKatherine1HesselingAnneke C.3[1], Department of Medicine, Division of Infectious Diseases," exact="Johns Hopkins University" post="School of Medicine, Baltimore, Maryland, United States of America[2],"/>
  <result pre="Department of Medicine, Division of Infectious Diseases, Johns Hopkins University" exact="School of Medicine," post="Baltimore, Maryland, United States of America[2], Center for Biostatistics"/>
  <result pre="no competing interests exist. * E-mail: agupta25@jhmi.edu epub: 2019-8-8collection: 2019-8168e1002882(C)" exact="World Health Organization," post="2019Licensee Public Library of Science. This is an open"/>
  <result pre="Health and Human Development UM1AI106701http://orcid.org/0000-0001-7036-2718GuptaAmita AG is supported by the" exact="National Institutes of Health" post="(NIH) National Institute of Allergy and Infectious Diseases (NIAID)"/>
  <result pre="AG is supported by the National Institutes of Health (NIH)" exact="National Institute of Allergy and Infectious Diseases" post="(NIAID) (UM1AI069465, R01AI097494); NIH Eunice Kennedy Shriver National Institute"/>
  <result pre="and Infectious Diseases (NIAID) (UM1AI069465, R01AI097494); NIH Eunice Kennedy Shriver" exact="National Institute of Child Health and Human Development" post="(NICHD) (RO1HD081929, R01HD074944); NIH/NIAID/AmFAR (U01AI069907); and the Ujala, Gilead"/>
  <result pre="(HHSN275201800001I). AG and MDH are also supported by the NIH-funded" exact="AIDS Clinical Trials Group" post="Network (ACTG) NIH NIAID (UM1AI068634, UM1AI068636, and UM1AI106701 to"/>
  <result pre="greater likelihood of TB-related mortality [12]. In March 2018, the" exact="World Health Organization" post="(WHO) held a technical consultation focused on advancing clinical"/>
  <result pre="and diethylstilbestrol in the 1960s and 1970s, the United States" exact="Food and Drug Administration" post="(FDA) enacted policies to protect women research participants of"/>
  <result pre="appropriate doses for optimal therapeutic effect [23,24], and WHO and" exact="Centers for Disease Control and Prevention" post="(CDC) recommend conflicting treatment guidelines for drug-susceptible TB (i.e.,"/>
  <result pre="Association and other non-FDA agencies outside the US. Abbreviations: CDC," exact="Centers for Disease Control and Prevention;" post="CNS, central nervous system; FDA, Food and Drug Administration;"/>
  <result pre="for Disease Control and Prevention; CNS, central nervous system; FDA," exact="Food and Drug Administration;" post="NNRTI, nonnucleoside reverse transcriptase inhibitor; PI, protease inhibitor; PK,"/>
  <result pre="transcriptase inhibitor; PI, protease inhibitor; PK, pharmacokinetics; UD, undetermined; WHO," exact="World Health Organization" post="TB trial design considerations and recommendations for pregnant and"/>
  <result pre="P; 3HP, 3 months of weekly H and P; ACTG," exact="AIDS Clinical Trials Group;" post="ARV, antiretroviral; BDQ, bedaquiline; CROI, Conference on Retroviruses and"/>
  <result pre="isoniazid preventive therapy; LTBI, latent TB infection; MDR, multidrug-resistant; MRC," exact="Medical Research Council;" post="NIH, National Institutes of Health; NIAID, National Institute of"/>
  <result pre="latent TB infection; MDR, multidrug-resistant; MRC, Medical Research Council; NIH," exact="National Institutes of Health;" post="NIAID, National Institute of Allergy and Infectious Diseases; NICHD,"/>
  <result pre="MRC, Medical Research Council; NIH, National Institutes of Health; NIAID," exact="National Institute of Allergy and Infectious Diseases;" post="NICHD, Eunice Kennedy Shriver National Institute of Child Health"/>
  <result pre="Institute of Allergy and Infectious Diseases; NICHD, Eunice Kennedy Shriver" exact="National Institute of Child Health and Human Development;" post="P, rifapentine; PD, pharmacodynamics; PK, pharmacokinetics; TB, tuberculosis; TBD,"/>
  <result pre="and adolescents &amp;lt;12 years old, HIV+/− Multisite international Planned iTIPS/NCT02613169" exact="Thrasher Research Fund" post="II LTBI Efficacy of INH to prevent MTB in"/>
  <result pre="H Infants (6 weeks), HIV-exposed Kenya Fully accrued P4v9 Trial/NCT00170209" exact="Canadian Institutes of Health Research" post="III LTBI Efficacy, safety, and tolerability of R and"/>
  <result pre="weeks), HIV-exposed Kenya Fully accrued P4v9 Trial/NCT00170209 Canadian Institutes of" exact="Health Research" post="III LTBI Efficacy, safety, and tolerability of R and"/>
  <result pre="Uganda, Zambia, South Africa Fully accrued SURE-TBM/ISRCTN40829906 MRC, DFID, NIHR," exact="Wellcome Trust" post="III DS Efficacy and safety of high-dose R, Le,"/>
  <result pre="rifapentine; 3HP, 3 months of weekly isoniazid and rifapentine; AECID," exact="Agencia Española de Cooperación Internacional para el Desarrollo" post="(Spanish Agency for International Development Corporation); ART, antiretroviral therapy;"/>
  <result pre="AFD, French Development Agency; ATT, antituberculosis therapy; BDQ, bedaquiline; CDC," exact="Centers for Disease Control and Prevention;" post="De, delamanid; DFID, British Department for International Development; DS,"/>
  <result pre="Centers for Disease Control and Prevention; De, delamanid; DFID, British" exact="Department for International Development;" post="DS, drug-sensitive; DR, drug-resistant; E, ethambutol; FQ, fluoroquinolone; H,"/>
  <result pre="ethambutol; FQ, fluoroquinolone; H, isoniazid; HIV, human immunodeficiency virus; ICMR," exact="Indian Council of Medical Research;" post="IGRA, interferon gamma release assay; IMPAACT, International Maternal Pediatric"/>
  <result pre="lopinavir; LTBI, latent TB infection; Mo, moxifloxacin; MDR, multidrug-resistant; MRC," exact="Medical Research Council;" post="MSF, Médecins Sans Frontières; NACO, National AIDS Control Organization;"/>
  <result pre="infection; Mo, moxifloxacin; MDR, multidrug-resistant; MRC, Medical Research Council; MSF," exact="Médecins Sans Frontières;" post="NACO, National AIDS Control Organization; NIAID, National Institute of"/>
  <result pre="MSF, Médecins Sans Frontières; NACO, National AIDS Control Organization; NIAID," exact="National Institute of Allergy and Infectious Diseases;" post="NICHD, Eunice Kennedy Shriver National Institute of Child Health"/>
  <result pre="Institute of Allergy and Infectious Diseases; NICHD, Eunice Kennedy Shriver" exact="National Institute of Child Health and Human Development;" post="NIH, National Institutes of Health; NIHR, National Institute for"/>
  <result pre="Shriver National Institute of Child Health and Human Development; NIH," exact="National Institutes of Health;" post="NIHR, National Institute for Health Research; NRTI, nucleoside reverse"/>
  <result pre="Health and Human Development; NIH, National Institutes of Health; NIHR," exact="National Institute for Health Research;" post="NRTI, nucleoside reverse transcriptase inhibitor; NVP, nevirapine; OBR, optimized"/>
  <result pre="Development; NIH, National Institutes of Health; NIHR, National Institute for" exact="Health Research;" post="NRTI, nucleoside reverse transcriptase inhibitor; NVP, nevirapine; OBR, optimized"/>
  <result pre="TBTC, Tuberculosis Trials Consortium; TST+, tuberculin skin test positive; WHO," exact="World Health Organization;" post="XDR, extremely drug-resistant; Z, pyrazinamide Trial designs for active"/>
  <result pre="exclusion criteria stated Korea Enrolling TBTC Study 31 ACTG 5349/NCT02410772" exact="AIDS Clinical Trials Group," post="CDC III DS Efficacy of 2 shortened rifapentine-containing regimens"/>
  <result pre="included regardless of status Belarus, South Africa, Uzbekistan Enrolling NExT-5001/NCT02454205" exact="University of Cape Town" post="II/III DR Efficacy, safety, tolerability of shortened, injection-free regimen"/>
  <result pre="Abbreviations: 3HP, 3 months of weekly isoniazid and rifapentine; ACTG," exact="AIDS Clinical Trials Group;" post="AFB, acid-fast bacilli; ART, antiretroviral therapy; ARV, antiretroviral; ATT,"/>
  <result pre="ethambutol; EDCTP, European &amp;amp; Developing Countries Clinical Trials Partnership; FDA," exact="Food and Drug Administration;" post="FQ, fluoroquinolone; HIV, human immunodeficiency virus; H, isoniazid; IUATLD,"/>
  <result pre="Administration; FQ, fluoroquinolone; HIV, human immunodeficiency virus; H, isoniazid; IUATLD," exact="International Union Against Tuberculosis and Lung Disease" post="(The Union); Le, levofloxacin; Li, linezolid; LTBI, latent TB"/>
  <result pre="linezolid; LTBI, latent TB infection; MDR, multidrug-resistant; Mo, moxifloxacin; MSF," exact="Médecins Sans Frontières;" post="NIAID, National Institute of Allergy and Infectious Diseases; NIH,"/>
  <result pre="infection; MDR, multidrug-resistant; Mo, moxifloxacin; MSF, Médecins Sans Frontières; NIAID," exact="National Institute of Allergy and Infectious Diseases;" post="NIH, National Institutes of Health; NRTI, nucleoside reverse transcriptase"/>
  <result pre="Frontières; NIAID, National Institute of Allergy and Infectious Diseases; NIH," exact="National Institutes of Health;" post="NRTI, nucleoside reverse transcriptase inhibitor; OBR, optimized background regimen;"/>
  <result pre="Tuberculosis Trials Consortium; THINK, TB&amp;amp;HIV Investigative Network; U, sutezolid; USAID," exact="United States Agency for International Development;" post="WHO, World Health Organization; XDR, extremely drug-resistant; Z, pyrazinamide"/>
  <result pre="U, sutezolid; USAID, United States Agency for International Development; WHO," exact="World Health Organization;" post="XDR, extremely drug-resistant; Z, pyrazinamide Trial design considerations and"/>
  <result pre="rifapentine 3HP 3 months of weekly isoniazid and rifapentine ACTG" exact="AIDS Clinical Trials Group" post="AECID Agencia Española de Cooperación Internacional para el Desarrollo"/>
  <result pre="weekly isoniazid and rifapentine ACTG AIDS Clinical Trials Group AECID" exact="Agencia Española de Cooperación Internacional para el Desarrollo" post="(Spanish Agency for International Development Corporation AFB acid-fast bacilli"/>
  <result pre="French Development Agency ART antiretroviral therapy ATT antituberculosis therapy CDC" exact="Centers for Disease Control and Prevention" post="CROI Conference on Retroviruses and Opportunistic Infections DDI drug–drug"/>
  <result pre="on Retroviruses and Opportunistic Infections DDI drug–drug interaction DFID British" exact="Department for International Development" post="DOOR desirability of outcome ranking DR drug-resistant DS drug"/>
  <result pre="sensitive EDCTP European &amp;amp; Developing Countries Clinical Trials Partnership FDA" exact="Food and Drug Administration" post="FQ fluoroquinolone IMPAACT International Maternal Pediatric Adolescent AIDS Clinical"/>
  <result pre="IMPAACT International Maternal Pediatric Adolescent AIDS Clinical Trials Network ICMR" exact="Indian Council of Medical Research" post="IGRA interferon gamma release assay IPT isoniazid preventive therapy"/>
  <result pre="IPT isoniazid preventive therapy IRIS immune reconstitution inflammatory syndrome IUATLD" exact="International Union Against Tuberculosis and Lung Disease" post="(The Union) LPV lopinavir LTBI latent TB infection MDR"/>
  <result pre="Union) LPV lopinavir LTBI latent TB infection MDR multidrug-resistant MRC" exact="Medical Research Council" post="MSF Médecins Sans Frontières NACO National AIDS Control Organization"/>
  <result pre="latent TB infection MDR multidrug-resistant MRC Medical Research Council MSF" exact="Médecins Sans Frontières" post="NACO National AIDS Control Organization NIAID National Institute of"/>
  <result pre="MSF Médecins Sans Frontières NACO National AIDS Control Organization NIAID" exact="National Institute of Allergy and Infectious Diseases" post="NICHD Eunice Kennedy Shriver National Institute of Child Health"/>
  <result pre="Institute of Allergy and Infectious Diseases NICHD Eunice Kennedy Shriver" exact="National Institute of Child Health and Human Development" post="NIH National Institutes of Health NIHR National Institute for"/>
  <result pre="Shriver National Institute of Child Health and Human Development NIH" exact="National Institutes of Health" post="NIHR National Institute for Health Research NRTI nucleoside reverse"/>
  <result pre="Health and Human Development NIH National Institutes of Health NIHR" exact="National Institute for Health Research" post="NRTI nucleoside reverse transcriptase inhibitor NNRTI nonnucleoside reverse transcriptase"/>
  <result pre="Development NIH National Institutes of Health NIHR National Institute for" exact="Health Research" post="NRTI nucleoside reverse transcriptase inhibitor NNRTI nonnucleoside reverse transcriptase"/>
  <result pre="THINK TB&amp;amp;HIV Investigative Network TST+ tuberculin skin test positive USAID" exact="United States Agency for International Development" post="WHO World Health Organization XDR extremely drug-resistant References References"/>
  <result pre="test positive USAID United States Agency for International Development WHO" exact="World Health Organization" post="XDR extremely drug-resistant References References 1collab: World Health Organization."/>
  <result pre="WHO World Health Organization XDR extremely drug-resistant References References 1collab:" exact="World Health Organization." post="Global Tuberculosis Report2018Geneva, Switzerland: WHO: 2018 [cited 2019 Dec"/>
  <result pre="and insights. Curr Opin HIV AIDS. 2018;13(6):486–91. 10.1097/COH.0000000000000495 .30080683 13collab:" exact="World Health Organization." post="Report of the technical consultation on advances in clinical"/>
  <result pre="call for innovation. PLoS Med. 2019;16(3):e1002769 Epub 2019/03/23. 10.1371/journal.pmed.100276930901322 15US" exact="Department of Health" post="and Human Services. Protection of human subjects. 2009 [cited"/>
  <result pre="of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric" exact="AIDS Clinical Trials Group" post="Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173–80."/>
  <result pre="management, and research gaps. Clin Infect Dis. 2012;55(11):1532–49. 10.1093/cid/cis73222942202 23collab:" exact="Food and Drug Administration." post="Pregnant Women: Scientific and Ethical Considerations for Inclusion in"/>
  <result pre="for Inclusion in Clinical TrialsGuidance for Industry. Silver Spring, MD:" exact="Food and Drug Administration;" post="2018 [cited 2018 Dec 14]. Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM603873.pdf. 24SheffieldJS,"/>
  <result pre="for pregnant women. Clin Infect Dis. 2014;59Suppl 7:S437–44. 10.1093/cid/ciu70925425722 25collab:" exact="Centers for Disease Control and Prevention." post="Treatment of tuberculosis. MMWR Recommendations and reports: Morbidity and"/>
  <result pre="/ Centers for Disease Control. 2003;52(RR-11):1–77. Epub 2003/07/03. .12836625 26collab:" exact="World Health Organization." post="Treatment of Tuberculosis: Guidelines. Geneva: World Health Organization; 2010."/>
  <result pre=".12836625 26collab: World Health Organization. Treatment of Tuberculosis: Guidelines. Geneva:" exact="World Health Organization;" post="2010. 27BalanS, HassaliMAA, MakVSL. Two decades of off-label prescribing"/>
  <result pre="review. World J Pediatr. 2018;14(6):528–40. Epub 2018/09/16. 10.1007/s12519-018-0186-y .30218415 28collab:" exact="World Health Organization." post="Treatment of tuberculosis in childrenRapid Advice.Geneva: World Health Organization;"/>
  <result pre="28collab: World Health Organization. Treatment of tuberculosis in childrenRapid Advice.Geneva:" exact="World Health Organization;" post="2010 [cited 2019 May 18]. Available from: https://www.who.int/tb/publications/tb-children-rapidadvice/en/. 29LyerlyA,"/>
  <result pre="extrapulmonary tuberculosis. N Engl J Med. 1999;341(9):645–9. 10.1056/NEJM199908263410903 .10460815 35collab:" exact="Food and Drug Administration." post="Guidance for Industry. Pharmacokinetics in Pregnancy—Study Design, Data Analysis,"/>
  <result pre="Analysis, and Impact on Dosing and Labeling. Silver Spring, MD:" exact="Food and Drug Administration;" post="2004 [cited 2014 Mar 12]. Available from: http://www.fda.gov/downloads/Drugs/…/Guidances/ucm072133.pdf. 36FrederiksenMC."/>
  <result pre="Registry2012 - [cited 2019 Jan 2]. Available from: http://www.apregistry.com/. 40collab:" exact="Food and Drug Administration." post="Guidance for Industry: Establishing Pregnancy Exposure Registries. Silver Spring,"/>
  <result pre="Guidance for Industry: Establishing Pregnancy Exposure Registries. Silver Spring, MD:" exact="Food and Drug Administration;" post="2002 [cited 2014 Mar 13]. Available from: https://www.fda.gov/media/75607/download. 41McIlleronH,"/>
  <result pre="Immune Defic Syndr. 2012;60(3):321–7. Epub 2012/02/22. 10.1097/QAI.0b013e31824e9ef222343179 68collab: United States" exact="Department of Health" post="and Human Services [Internet]. Guidelines for the Use of"/>
  <result pre="Adults and Adolescents Living with HIV. Washington DC: United States" exact="Department of Health" post="and Human Services c2018 [cited 2019 Jan 2]. Available"/>
  <result pre="Services c2018 [cited 2019 Jan 2]. Available from: https://aidsinfo.nih.gov/guidelines. 69collab:" exact="World Health Organization." post="Consolidated guidelines on the use of antiretroviral drugs for"/>
  <result pre="use of antiretroviral drugs for treating and preventing HIV infectionGeneva:" exact="World Health Organization;" post="2016 [cited 2019 May 18]. Available from: https://www.who.int/hiv/pub/arv/arv-2016/en/. 70Guidelines"/>
  <result pre="Infections in Adults and Adolescents with HIV [Internet]. Washington, DC:" exact="U.S. Department of Health and Human Services;" post="[cited 2019 May 18]. Available from: https://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-opportunistic-infection/325/mycobacterium-tuberculosis. 71BrooksKM, GeorgeJM,"/>
  <result pre="in Adults and Adolescents with HIV [Internet]. Washington, DC: U.S." exact="Department of Health" post="and Human Services; [cited 2019 May 18]. Available from:"/>
 </snippets>
</snippetsTree>
